23 May 2013
Keywords: Japan, Business models, Licensing, Marketing authorizations, Partnerships, P Reed Maurer
Article | 11 June 2012
A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical trials, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 2012
22 May 2013
© 2013 thepharmaletter.com